-
June 11, 2013
The debate about data transparency has returned to the spotlight following an investigation into the safety of new diabetes drugs by the BMJ and the Channel 4 programme Dispatches
Full story
-
May 02, 2013
Merck & Co has suffered a decline in sales and profits in the first quarter, hit by patent expiries on Singulair and disappointing sales for some big-earners, notably Januvia
Full story
-
April 30, 2013
Drug giants Merck & Co and Pfizer have formed a new alliance to jointly develop and commercialise the latter's ertugliflozin for the treatment of type II diabetes
Full story
-
April 08, 2013
Merck & Co's bid to prevent Glenmark Pharmaceuticals from selling copycat forms of its diabetes drugs Januvia and Janumet has suffered a setback in India
Full story
-
April 03, 2013
US drug giant Merck & Co has dragged Indian generic drugmaker Glenmark Pharmaceuticals to court in a bid to stop it from selling copycat forms of its diabetes drugs Januvia and Janumet.
Full story
-
March 27, 2013
The European Medicines Agency is following a move by its counterpart across the Atlantic and is investigating the possibility of an increased risk to the pancreas linked to use of new diabetes drugs
Full story
-
November 14, 2012
US drug giant Merck & Co has pulled the plug on an experimental combination of its diabetes drug Januvia and the cholesterol buster atorvastatin.
Full story
-
October 29, 2012
Merck & Co's third-quarter earnings have edged up 2%, helped by tax gains, as new products helped soften the blow of losing US patent protection on its blockbuster Singulair
Full story
-
July 30, 2012
Merck & Co's second-quarter earnings have fallen 11.4% as a result of acquisition and restructuring charges, but revenues have edged up 1.3%, aided by the diabetes drugs Januvia and Janumet
Full story
-
July 12, 2012
UK drug giant GlaxoSmithKline is planning to file for approval of albiglutide as a diabetes treatment early next year, after the drug turned in a solid performance in its Phase III clinical trial programme.
Full story